Navigation Links
GPhA's 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts

Thurs.-Fri., Sept. 6-7, Mandarin Oriental, Washington, D.C.

ARLINGTON, Va., Aug. 30 /PRNewswire/ -- Three leading generic industry CEOs, along with top Wall Street analysts and key Food and Drug Administration (FDA) and other government officials, will headline the Generic Pharmaceutical Association's (GPhA) Annual Policy Conference on September 6-7, 2007. The conference, "Generics: Prescription for Affordable Health Care," will focus on the legislative, regulatory and business issues that will shape the generic industry in the coming years.

"This conference will look at the wide range of issues affecting the generic industry's efforts to provide consumers with timely access to affordable medicines," said Kathleen Jaeger, GPhA President and CEO. "From regulations to legislation, the industry is facing a series of unique opportunities and challenges."

The conference features keynote presentations from Hospira, Inc. Chairman and CEO Christopher Begley, Mylan Laboratories CEO Robert Coury, and Actavis President and CEO Robert Wessman.

Conference speakers also include U.S. Representatives Henry Waxman (D-CA) and Frank Pallone (D-NJ), FDA Deputy Commissioner Dr. Janet Woodcock, FDA Chief Counsel Sheldon Bradshaw, IMS Health Vice President Doug Long, UBS Warburg Healthcare Banking Director Tommy Erdei, Lehman Brothers Senior Vice President Richard Silver, and Roundtable Healthcare Partners Senior Partner David Koo, among other industry experts. In addition, the conference has special track sessions on federal legislation and legal issues, which will take place on September 6.

GPhA's Annual Policy Conference will be held at the Mandarin Oriental Hotel, 1330 Maryland Avenue, S.W., in Washington, D.C. The conference begins at 8 a.m. on both days. The conference agenda is available online at

For registration information, go to Credentialed media can register at no charge by contacting Andrea Hofelich at 703-647-2495.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 63% of the total prescriptions dispensed in the United States, but only 20% of all dollars spent on prescription drugs. For further information, please contact GPhA at 703-647-2480, or visit our web site at

Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Annual PSA screening reduces risk of prostate cancer deaths
2. Low turnover by Diabetics for free annual checkup
3. UK Spends ?7.3 Billion Annually On Malnutrition Cost
4. Annual Dental Checkups in Children Lagging Behind
5. Annual Budget 2006: Health And Education Sector Receive A Boost
6. Breast cancer survivors slacken on mandated annual mammograms
7. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
8. Medical Tourism can Fetch Rs.100 bn Annually by 2012
9. Annual Conference Of Plastic Surgeons In US To Focus On The Future Of Plastic Surgery
10. Jamaica Sees 1000 New Cases of HIV Annually
11. More Indians Die of Rabies Annually
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: